Quoin Pharmaceuticals, Ltd. American Depositary Shares
Compare this stock
QNRX Stock Report Card
$
17%
Performance
Score:
10/100
QNRX returned -81.93% in the last 12 months. Based on SPY's performance of 13.09%, its performance is below average giving it a score of 10 of 100.
Technicals
Score:
29/100
QNRX receives a 28 of 100 based on 14 indicators. 3 are bullish, 9 are bearish.
Earnings
Score:
10/100
QNRX has missed earnings 5 times in the last 20 quarters.
Profit
Score:
10/100
Out of the last 14 quarters, QNRX has had 0 profitable quarters and has increased their profits year over year on 0 of them.
Volatility
Score:
35/100
QNRX has had a lower than average amount of volatility over the last 12 months giving it a score of 35 of 100.
Quoin Pharmaceuticals, Ltd. American Depositary Shares Summary
Nasdaq / QNRX
Healthcare
Biotechnology
Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome. It also develops QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease. The company is based in Ashburn, Virginia.
Power up your portfolio
Build a portfolio of your favorite stocks
Pluto makes it easy to build investing strategies and automate your portfolio
Checkout Similar Companies
QNRX scored poorly on our reportcard. Here are some similar companies and how they performed.
